Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 701 | Cord Tissue | Allogeneic – Unrelated | Degenerative and traumatic cartilage damage | Orthopedics | 2025 | Experimental Therapy | Poland | 57 |
| 702 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 3 |
| 703 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 3 |
| 704 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 2 |
| 705 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 |
| 706 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 11 |
| 707 | Cord Tissue | Allogeneic – Unrelated | Degenerative and traumatic cartilage damage | Orthopedics | 2025 | Experimental Therapy | Poland | 54 |
| 708 | Cord Tissue | Allogeneic – Unrelated | Degenerative and traumatic cartilage damage | Orthopedics | 2025 | Experimental Therapy | Poland | 78 |
| 709 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 6 |
| 710 | Cord Tissue | Allogeneic – Unrelated | Degenerative and traumatic cartilage damage | Orthopedics | 2025 | Experimental Therapy | Poland | 58 |
| 711 | Cord Tissue | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Romania | 5 |
| 712 | Cord Tissue | Allogeneic – Related | Autism | Neurology | 2025 | Experimental Therapy | Romania | 5 |
| 713 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 4 |
| 714 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 7 |
| 715 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7 |
| 716 | Cord Tissue | Allogeneic – Unrelated | Degenerative and traumatic cartilage damage | Orthopedics | 2025 | Experimental Therapy | Poland | 25 |
| 717 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 6 |
| 718 | Cord Tissue | Allogeneic – Unrelated | Progressive bulbar palsy | Neurology | 2025 | Experimental Therapy | Poland | 62 |
| 719 | Cord Tissue | Allogeneic – Unrelated | Encephalopathy | Neurology | 2025 | Experimental Therapy | Poland | 67 |
| 720 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7 |
| 721 | Cord Tissue | Allogeneic – Unrelated | Degenerative and traumatic cartilage damage | Orthopedics | 2025 | Experimental Therapy | Poland | 61 |
| 722 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 |
| 723 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 6 |
| 724 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 1 |
| 725 | Cord Tissue | Allogeneic – Unrelated | Myelitis | Neurology | 2025 | Experimental Therapy | Poland | 38 |
| 726 | Cord Tissue | Allogeneic – Unrelated | Anemia | Neurology | 2025 | Experimental Therapy | Poland | 3 |
| 727 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 6 |
| 728 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7 |
| 729 | Cord Tissue | Allogeneic – Unrelated | Spinocerebellar Ataxia | Neurology | 2025 | Experimental Therapy | Poland | 5 |
| 730 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 1 |
| 731 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 1 |
| 732 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 |
| 733 | Cord Tissue | Allogeneic – Unrelated | Progressive bulbar palsy | Neurology | 2025 | Experimental Therapy | Poland | 63 |
| 734 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 15 |
| 735 | Cord Tissue | Allogeneic – Unrelated | GvHD | Immunology | 2025 | Experimental Therapy | Poland | 13 |
| 736 | Cord Tissue | Allogeneic – Unrelated | Cartilage Lesions | Orthopedics | 2025 | Experimental Therapy | Poland | 48 |
| 737 | Cord Tissue | Allogeneic – Unrelated | Cartilage Lesions | Orthopedics | 2025 | Experimental Therapy | Poland | 51 |
| 738 | Cord Tissue | Allogeneic – Unrelated | GvHD | Hematology | 2025 | Experimental Therapy | Poland | 12 |
| 739 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 10 |
| 740 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 8 |
| 741 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 3 |
| 742 | Cord Tissue | Allogeneic – Unrelated | Cerebral Infarction | Neurology | 2025 | Experimental Therapy | Poland | 57 |
| 743 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7 |
| 744 | Cord Tissue | Allogeneic – Unrelated | Cerebellar Syndrome | Neurology | 2025 | Experimental Therapy | Poland | 43 |
| 745 | Cord Tissue | Allogeneic – Unrelated | Cartilage Lesions | Orthopedics | 2025 | Experimental Therapy | Poland | 61 |
| 746 | Cord Tissue | Allogeneic – Unrelated | Cartilage Lesions | Orthopedics | 2025 | Experimental Therapy | Poland | 57 |
| 747 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 1 |
| 748 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 7 |
| 749 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 3 |
| 750 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2025 | Standard Therapy | Turkey | 5 |
| 751 | Cord Blood | Autologous | Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 2 |
| 752 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2025 | Standard Therapy | Turkey | 6 |
| 753 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Portugal | 1 |
| 754 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Romania | 5 |
| 755 | Cord Blood | Allogeneic | Acute lymphoblastic leukemia | Hematology | 2025 | Standard Therapy | Poland | 13 |
| 756 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 |
| 757 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7 |
| 758 | Cord Blood | Allogeneic | Thalassemia Major | Hematology | 2025 | Standard Therapy | Turkey | 10 |
| 759 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 4 |
| 760 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 3 |
| 761 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 |
| 762 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 2 |
| 763 | Cord Blood | Autologous | Unbalanced AVSD | Cardiovascular | 2025 | Experimental Therapy | Poland | 5 |
| 764 | Cord Blood | Allogeneic – Related | Relapsed Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Turkey | 8 |
| 765 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 10 |
| 766 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 |
| 767 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 4 |
| 768 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 |
| 769 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 |
| 770 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 3 |
| 771 | Cord Blood | Allogeneic – Related | D57.1 Sickle Cell Anemia | Hematology | 2025 | Standard Therapy | Turkey | 5 |
| 772 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 66 |
| 773 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 63 |
| 774 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | Poland | 71 |
| 775 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 72 |
| 776 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 47 |
| 777 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Ukraine | 43 |
| 778 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 49 |
| 779 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 51 |
| 780 | Bone Marrow Family | Allogeneic | Philadelphia – positive Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Germany | 61 |
| 781 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 58 |
| 782 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | NETHERLANDS | 63 |
| 783 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
| 784 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | France | 63 |
| 785 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 68 |
| 786 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | France | 71 |
| 787 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Russia | 51 |
| 788 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 789 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Czechia | 54 |
| 790 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 16 |
| 791 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 61 |
| 792 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 61 |
| 793 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 70 |
| 794 | Bone Marrow Family | Allogeneic | PostET Myelofibrosis | Hematology | 2025 | Standard Therapy | Netherlands | 21 |
| 795 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 68 |
| 796 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia/ Mielodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 65 |
| 797 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | NETHERLANDS | 60 |
| 798 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 33 |
| 799 | Bone Marrow Family | Allogeneic | Muscular Dystrophy Association | Hematology | 2025 | Standard Therapy | United Kingdom | 75 |
| 800 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2025 | Standard Therapy | Germany | 72 |